Why Evolus Could Rocket Higher
For such a small company Evolus (EOLS) sure has made a lot of noise over the past few months. Evolus has a market capitalization...
Endo Hints It Could Accelerate Timelines For Key Drug
Over the past year I did some work on drug companies caught up in the opioid crisis and it was not pretty. When I...
Endo: A Major Seal Of Approval From Merck?
In the past I have been extremely bearish on Endo International (ENDP). I tend to follow trends on revenue and earnings. Drug companies like...
‘Trump Baby’ Blimp Flies In London Ahead Of Visit
Making friends and influencing people appears to be President Trump's specialty. Love him or hate him, you have to react to Trump and you...
Endo: Which Hedge Funds Pile In Next? #6 Dan Loeb
Endo International's share price has taken a pounding over the past year. ENDP is down over 7% Y/Y; meanwhile, the S&P 500 and Dow...
DeMarcus Cousins To The Warriors … Really?
Last week a headline flashed across my computer screen that New Orleans Pelicans forward DeMarcus Cousins had signed with the Golden State Warriors in...
Endo International: Will Hedge Funds Pile In?
The fortunes of Endo International are starting to turn. The stock is down about 7% Y/Y, but has bounced over 40% YTD. Albeit, the...
Amgen Takes A Bite Out Of Allergan
Companies like Allergan (AGN), Valeant (VRX) and Mallinckrodt (MNK) have become synonymous with the rising costs of drugs, and price-gouging by drug companies. Allergan...
BlackRock’s Larry Fink Makes Colossal Bet On Endo
Endo Pharmaceuticals' (ENDP) fortunes appear to have taken a turn for the better. In May I suggested that exciting drugs in its pipeline could...
Trump And The GE: How Trump Can Energize His Republican Base
President Donald Trump shocked the world in November 2016 with his presidential victory over Hillary Clinton. Ralph Baker, author of Shock Exchange: How Inner-City...
